Mineralys Therapeutics CMO David Malcom Rodman disposes of USD 559,234 in common shares - MLYS News | RalliesMineralys Therapeutics CMO David Malcom Rodman disposes of USD 559,234 in common shares
M
MLYS• Rodman trims Mineralys stake after option exercises and sales
- Mineralys Therapeutics Chief Medical Officer Rodman David Malcom cut his stake to 51,384 shares following option exercises and stock sales.
- Malcom exercised stock options for 14,058 shares on July 13 at prices from $1.08 to $14.25.
- He sold 20,407 shares on July 13-15 at weighted-average prices of $27.58 and $26.61.
PSNL
•
